BACKGROUND AND AIMS: SPDEF (also termed PDEF or PSE) is an ETS family transcription factor that regulates gene expression in the prostate and goblet cell hyperplasia in the lung. Spdef has been reported to be expressed in the intestine. In this paper, we identify an important role for Spdef in regulating intestinal epithelial cell homeostasis and differentiation. METHODS: SPDEF expression was inhibited in colon cancer cells to determine its ability to control goblet cell gene activation. The effects of transgenic expression of Spdef on intestinal differentiation and homeostasis were determined. RESULTS: In LS174T colon cancer cells treated with Notch/gamma-secretase inhibitor to activate goblet cell gene expression, shRNAs that inhibited SPDEF also repressed expression of goblet cell genes AGR2, MUC2, RETLNB, and SPINK4. Transgenic expression of Spdef caused the expansion of intestinal goblet cells and corresponding reduction in Paneth, enteroendocrine, and absorptive enterocytes. Spdef inhibited proliferation of intestinal crypt cells without induction of apoptosis. Prolonged expression of the Spdef transgene caused a progressive reduction in the number of crypts that expressed Spdef, consistent with its inhibitory effects on cell proliferation. CONCLUSIONS: Spdef was sufficient to inhibit proliferation of intestinal progenitors and induce differentiation into goblet cells; SPDEF was required for activation of goblet cell associated genes in vitro. These data support a model in which Spdef promotes terminal differentiation into goblet cells of a common goblet/Paneth progenitor. Copyright 2009 Elsevier Inc. All rights reserved.
BACKGROUND AND AIMS: SPDEF (also termed PDEF or PSE) is an ETS family transcription factor that regulates gene expression in the prostate and goblet cell hyperplasia in the lung. Spdef has been reported to be expressed in the intestine. In this paper, we identify an important role for Spdef in regulating intestinal epithelial cell homeostasis and differentiation. METHODS:SPDEF expression was inhibited in colon cancer cells to determine its ability to control goblet cell gene activation. The effects of transgenic expression of Spdef on intestinal differentiation and homeostasis were determined. RESULTS: In LS174Tcolon cancer cells treated with Notch/gamma-secretase inhibitor to activate goblet cell gene expression, shRNAs that inhibited SPDEF also repressed expression of goblet cell genes AGR2, MUC2, RETLNB, and SPINK4. Transgenic expression of Spdef caused the expansion of intestinal goblet cells and corresponding reduction in Paneth, enteroendocrine, and absorptive enterocytes. Spdef inhibited proliferation of intestinal crypt cells without induction of apoptosis. Prolonged expression of the Spdef transgene caused a progressive reduction in the number of crypts that expressed Spdef, consistent with its inhibitory effects on cell proliferation. CONCLUSIONS:Spdef was sufficient to inhibit proliferation of intestinal progenitors and induce differentiation into goblet cells; SPDEF was required for activation of goblet cell associated genes in vitro. These data support a model in which Spdef promotes terminal differentiation into goblet cells of a common goblet/Paneth progenitor. Copyright 2009 Elsevier Inc. All rights reserved.
Authors: C M Steppan; E J Brown; C M Wright; S Bhat; R R Banerjee; C Y Dai; G H Enders; D G Silberg; X Wen; G D Wu; M A Lazar Journal: Proc Natl Acad Sci U S A Date: 2001-01-16 Impact factor: 11.205
Authors: M Mitas; K Mikhitarian; L Hoover; M A Lockett; L Kelley; A Hill; W E Gillanders; D J Cole Journal: Br J Cancer Date: 2002-03-18 Impact factor: 7.640
Authors: Wouter Bossuyt; Avedis Kazanjian; Natalie De Geest; Sofie Van Kelst; Gert De Hertogh; Karel Geboes; Greg P Boivin; Judith Luciani; Francois Fuks; Marinee Chuah; Thierry VandenDriessche; Peter Marynen; Jan Cools; Noah F Shroyer; Bassem A Hassan Journal: PLoS Biol Date: 2009-02-24 Impact factor: 8.029
Authors: Kelli L VanDussen; Alexis J Carulli; Theresa M Keeley; Sanjeevkumar R Patel; Brent J Puthoff; Scott T Magness; Ivy T Tran; Ivan Maillard; Christian Siebel; Åsa Kolterud; Ann S Grosse; Deborah L Gumucio; Stephen A Ernst; Yu-Hwai Tsai; Peter J Dempsey; Linda C Samuelson Journal: Development Date: 2011-12-21 Impact factor: 6.868
Authors: Roni Nowarski; Ruaidhrí Jackson; Nicola Gagliani; Marcel R de Zoete; Noah W Palm; Will Bailis; Jun Siong Low; Christian C D Harman; Morven Graham; Eran Elinav; Richard A Flavell Journal: Cell Date: 2015-12-03 Impact factor: 41.582
Authors: Denise Al Alam; Soula Danopoulos; Kathy Schall; Frederic G Sala; Dana Almohazey; G Esteban Fernandez; Senta Georgia; Mark R Frey; Henri R Ford; Tracy Grikscheit; Saverio Bellusci Journal: Am J Physiol Gastrointest Liver Physiol Date: 2015-02-26 Impact factor: 4.052
Authors: Alexis J Carulli; Theresa M Keeley; Elise S Demitrack; Jooho Chung; Ivan Maillard; Linda C Samuelson Journal: Dev Biol Date: 2015-03-30 Impact factor: 3.582
Authors: Taeko K Noah; Kathryn A Knoop; Keely G McDonald; Jenny K Gustafsson; Lisa Waggoner; Simone Vanoni; Matthew Batie; Kavisha Arora; Anjaparavanda P Naren; Yui-Hsi Wang; Nicholas W Lukacs; Ariel Munitz; Michael A Helmrath; Maxime M Mahe; Rodney D Newberry; Simon P Hogan Journal: J Allergy Clin Immunol Date: 2019-06-05 Impact factor: 10.793
Authors: Christina Kaiser Marko; Ann S Tisdale; Sandra Spurr-Michaud; Christopher Evans; Ilene K Gipson Journal: Invest Ophthalmol Vis Sci Date: 2014-01-15 Impact factor: 4.799
Authors: Julian Heuberger; Frauke Kosel; Jingjing Qi; Katja S Grossmann; Klaus Rajewsky; Walter Birchmeier Journal: Proc Natl Acad Sci U S A Date: 2014-02-18 Impact factor: 11.205